The American Academy of Neurology has published a new guideline on more effective treatments for diabetic nerve pain, burning or tingling in hands and feet which affects millions of people with diabetes.
The guideline is published in the April 11, 2011 of Neurology; online, the American Academy of medical neurology journal and will be presented April 11, 2011, at the American Academy of Neurology at the Honolulu annual meeting.
This guide has been developed in collaboration with the American Association of neuromuscular and electrodiagnostic medicine and the American Academy of physical medicine and rehabilitation.
Diabetic neuralgia or neuropathy, is caused by neurological damage. "When neuropathy, is painful and can disrupt sleep;" because of "it can also lead to changes in mood and low quality of life, said guideline lead author Vera Bril, MD, FRCP, with the University of Toronto and a member of the American Academy of Neurology. It has been estimated that the pain of diabetic nerve affects 16 percent of the more than 25 million people with diabetes in the United States and is often regulated and more frequently without treatment, with an estimated two of every five cases which require attention.
Directive, the evidence shows the seizure of drug Pregabalin is effective in the treatment of diabetic nerve pain and can improve the quality of life; However, doctors must determine whether it is appropriate for your patients on the basis of case by case.
In addition, the guideline found that various other treatments are probably and should be considered, including taking medication Gabapentin and valproate, antidepressants, such as venlafaxine, Duloxetine and amitriptyline and opioid analgesics and capsaicin. Nerve electrical stimulation Transcutaneous (RTE), a therapy for pain used with a portable device, is also considered that probably effective for treating diabetic nerve pain.
"We're happy to see many of these treatments of pain were studies of high-quality in support of its use, said Bril." It is always important to make the research more showing how these treatments can be tolerated over time, as the diabetic nerve pain is a chronic disease that affects the quality of life of a person and the ability to function.
The recommendations in this guide will serve as a basis for a new set of tools that the AAN has created for doctors to measure the quality of care provided to people with nerve pain. The measures will be released in 2012.
The guidelines will appear also in the muscle magazine April issue and the American Association of neuromuscular and electrodiagnostic medicine and the April issue of the PM & R, of the American Academy of physical medicine and rehabilitation science magazine.
Social Plugin